Evaluation of the cytotoxic effects and apoptosis inducing of Cuscuta epithymum extract on esophageal squamous cell carcinoma

Background. Esophageal cancer is the eighth most common cancer in the world. The antitumor effects of medicinal plants have been shown as a therapeutic strategy to treat esophageal cancer. This study aimed to evaluate in vitro effects of Cuscuta epithymum extract on the survival and apoptosis of esophageal cancer cell line. Material and Methods. Here, the hydroalcoholic Soxhlet extract of C. epithymum plant was prepared. The cell viability of esophageal cancer cell line KYSE-30 was evaluated by MTT assay after 24 h treatment with concentrations of 50, 100, 200, 400, 600, 800 and 1000 μg/ml of the extract. Then, the apoptotic effect of extract was evaluated by flow cytometry using Propidium Iodide (PI) staining and sub-G1 peak analysis, and Annexin V-FITC/PI staining in cells treated with concentrations of 125, 250, 500 and 750 μg/ml as well as morphological change of healthy cells to apoptotic and necrotic form. Results. The hydroalcoholic extract of C. epithymum decreases the viability of KYSE-30 cells in a dose-dependent manner with an IC50 of 646 µg/ ml at 24 h. A significant increase was observed in the percentage of sub-G1 phase in cells treated with 500, 750, and 1000 μg/ml of C. epithymum extract for 24 h compared to the control group (p<0.01 and p<0.001). The results also showed a significantly enhanced the percentage of primary and secondary apoptotic cells compared to untreated cells. At concentrations of 250, 500, and 750 µg/ml, approximately 17, 33 and 45 % of cells was apoptotic. The apoptotic and necrotic cells morphology after treatment with 250 and 500 µg/ml of the extract was also confirmed by fluorescence microscopy. Conclusion. The findings showed the apoptotic effect of the hydroalcoholic extract of C. epithymum on KYSE-30 cells in vitro. The effect of this extract on the genes involved in apoptosis as well as the mechanism of action of this extract are recommended.

1. Liu C.Q., Ma Y.L., Qin Q., Wang P.H., Luo Y., Xu P.F., Cui Y. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac Cancer. 2023; 14(1): 3–11. doi: 10.1111/1759-7714.14745.

2. Uhlenhopp D.J., Then E.O., Sunkara T., Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020; 13(6): 1010–21. doi: 10.1007/s12328-020-01237-x.

3. Yang J., Liu X., Cao S., Dong X., Rao S., Cai K. Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade. Front Oncol. 2020; 10. doi: 10.3389/fonc.2020.01727.

4. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013; 19(34): 5598–606. doi: 10.3748/wjg.v19.i34.5598.

5. Li J., Xu J., Zheng Y., Gao Y., He S., Li H., Zou K., Li N., Tian J., Chen W., He J. Esophageal cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2021; 33(5): 535–47. doi: 10.21147/j.issn.1000-9604.2021.05.01.

6. Wang Q.L., Xie S.H., Wahlin K., Lagergren J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin Epidemiol. 2018; 10: 717–28. doi: 10.2147/CLEP.S166078.

7. Sheikh M., Roshandel G., McCormack V., Malekzadeh R. Current Status and Future Prospects for Esophageal Cancer. Cancers (Basel). 2023; 15(3): 765. doi: 10.3390/cancers15030765.

8. Yang Y.M., Hong P., Xu W. W., He Q.Y., Li B. Advances in targeted therapy for esophageal cancer. Signal Transduc Target Ther. 2020; 5(1). doi: 10.1038/s41392-020-00323-3.

9. Bollschweiler E., Plum P., Mönig S.P., Hölscher A.H. Current and future treatment options for esophageal cancer in the elderly. Expert Opin Pharmacother. 2017; 18(10): 1001–10. doi: 10.1080/14656566.2017.1334764.

10. Abbas G., Krasna M. Overview of esophageal cancer. Ann Cardiothorac Surg. 2017; 6(2): 131–6. doi: 10.21037/acs.2017.03.03.

11. Borggreve A.S., Kingma B.F., Domrachev S.A., Koshkin M.A., Ruurda J.P., van Hillegersberg R., Takeda F.R., Goense L. Surgical treatment of esophageal cancer in the era of multimodality management. Ann N Y Acad Sci. 2018; 1434(1): 192–209. doi: 10.1111/nyas.13677.

12. Ying J., Zhang M., Qiu X., Lu Y. The potential of herb medicines in the treatment of esophageal cancer. Biomed Pharmacother. 2018; 103: 381–90. doi: 10.1016/j.biopha.2018.04.088.

13. An J., An S., Choi M., Jung J.H., Kim B. Natural Products for Esophageal Cancer Therapy: From Traditional Medicine to Modern Drug Discovery. Int J Mol Sci. 2022; 23(21). doi: 10.3390/ijms232113558.

14. Noureen S., Noreen S., Ghumman S.A., Batool F., Bukhari S.N.A. The genus Cuscuta (Convolvolaceac): An updated review on indigenous uses, phytochemistry, and pharmacology. Iran J Basic Med Sci. 2019; 22(11): 1225–52. doi: 10.22038/ijbms.2019.35296.8407.

15. Ahmad A., Tandon S., Xuan T.D., Nooreen Z. A Review on Phytoconstituents and Biological activities of Cuscuta species. Biomed Pharmacother. 2017; 92: 772–95. doi: 10.1016/j.biopha.2017.05.124.

16. Pourhadi M., Niknam Z., Ghasemi R., Zomorrod M. S., Niazi V., Faizi M., Zali H., Mojab F. Cuscuta epithymum Murr. crude extract pre-conditioning inhibits cell apoptosis in glutamate-induced cytotoxic condition. 2022. doi: 10.21203/rs.3.rs-1950388/v1.

17. Abedini M. R., Paki S., Mohammadifard M., Foadoddini M., Vazifeshenas-Darmiyan K., Hosseini M. Evaluation of the in vivo and in vitro safety profile of Cuscuta epithymum ethanolic extract. Avicenna J Phytomed. 2021; 11(6): 645–56. doi: 10.22038/AJP.2021.18529.

18. Chabra A., Monadi T., Azadbakht M., Haerizadeh S.I. Ethnopharmacology of Cuscuta epithymum: A comprehensive review on ethnobotany, phytochemistry, pharmacology and toxicity. J Ethnopharmacol. 2019; 231: 555–69. doi: 10.1016/j.jep.2018.10.016.

19. Mishra S., Alhodieb F.S., Barkat M.A., Hassan M.Z., Barkat H.A., Ali R., Alam P., Alam O. Antitumor and hepatoprotective effect of Cuscuta reflexa Roxb. in a murine model of colon cancer. J Ethnopharmacol. 2022; 282. doi: 10.1016/j.jep.2021.114597.

20. Katiyar N.S. A Study on Hepatoprotective and Anti-Inflammatory Activities of Stem Extracts of Cuscuta Reflexa (Roxb) in Rats. Rajiv Gandhi University of Health Sciences. India, 2010.

21. Sylvester P.W. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol. 2011; 716: 157–68. doi: 10.1007/978-1-61779-012-6_9.

22. Nair A., Manohar S.M. A flow cytometric journey into cell cycle analysis. Bioanalysis. 2021; 13(21): 1627–44. doi: 10.4155/bio-2021-0071.

23. Rajagopal A., Rajakannu S. Cassia auriculata Linn. extracts induce apoptosis and cell cycle arrest of A549 lung cancer cell lines: An in vitro approach. South African Journal of Botany. 2022; 147: 275–85. doi: 10.1016/j.sajb.2022.01.020.

24. van Wyk A.S., Prinsloo G. Health, safety and quality concerns of plant-based traditional medicines and herbal remedies. South African Journal of Botany. 2020; 133: 54–62.

25. Welz A.N., Emberger-Klein A., Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018; 18(1): 92. doi: 10.1186/s12906-018-2160-6.

26. Ghazanfari T., Naseri M., Shams J., Rahmati B. Cytotoxic effects of Cuscuta extract on human cancer cell lines. Food Agric Immunol. 2013; 24(1): 87–94. doi: 10.1080/09540105.2011.648608.

27. Jafarian A., Ghannadi A., Mohebi B. Cytotoxic effects of chloroform and hydroalcoholic extracts of aerial parts of Cuscuta chinensis and Cuscuta epithymum on Hela, HT29 and MDA-MB-468 tumor cells. Res Pharm Sci. 2014; 9(2): 115–22.

28. Moradzadeh M., Hosseini A., Rakhshandeh H., Aghaei A., Sadeghnia H.R. Cuscuta campestris induces apoptosis by increasing reactive oxygen species generation in human leukemic cells. Avicenna J Phytomed. 2018; 8(3): 237–45.

29. Firoozan J., Khodaie L., Mohammadi A., Fazljou S. M., Torbati M., Mohammadi Q., Mansoori B., Moghadam S.B.,, Baradaran B. Dichloromethane EXTRACT of Cuscuta epithymum inhibits triple-negative breast cancer development via inducing apoptosis and suppression of migration. J Biochem Tech. 2020; 11(1): 92–9.

30. Bhagat M., Arora J.S., Saxena A.K. In vitro and in vivo antiproliferative potential of Cuscuta reflexa Roxb. J Pharm Res. 2013; 6(7): 690–5. doi: 10.1016/j.jopr.2013.06.005.

31. Behbahani M. Evaluation of in vitro anticancer activity of Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris. PLoS One. 2014; 9(12). doi: 10.1371/journal.pone.0116049.